Search

Your search keyword '"González Villanueva, Iris"' showing total 11 results
Start Over Author "González Villanueva, Iris"
11 results on '"González Villanueva, Iris"'

1. Long‐term secukinumab efficacy and safety in bio‐naïve patients with moderate‐to‐severe cutaneous psoriasis: A real‐world retrospective noninterventional multicentric experience (128 patients)

Author

Melgosa Ramos, Francisco Javier, primary, Mateu Puchades, Almudena, additional, Guillén Climent, Santiago, additional, Galarreta Pascual, Marta, additional, Saéz Belló, Marina, additional, Martínez Ferrer, María Angels, additional, Alberola, Fernando Toledo, additional, Magdaleno Tapial, Jorge, additional, Sánchez Carazo, Jose Luís, additional, Díaz, Javier Matáix, additional, Schneller‐Pavelescu Apetrei, Luca, additional, García Fernández, Laura, additional, González Villanueva, Iris, additional, Belinchón Romero, Isabel, additional, Martín Jiménez, Sergio, additional, and Santos Alarcón, Sergio, additional

Published
2023
Full Text
View/download PDF

2. No SARS‐CoV ‐2 antibody response in 25 patients with pseudo‐chilblains

Author

Docampo‐Simón, Alexandre, primary, Sánchez‐Pujol, María José, additional, Gimeno‐Gascon, Adelina, additional, Palazón‐Cabanes, Juan Carlos, additional, Juan‐Carpena, Gloria, additional, Vergara‐De Caso, Eduardo, additional, González‐Villanueva, Iris, additional, Blanes‐Martínez, Mar, additional, and Betlloch‐Mas, Isabel, additional

Published
2020
Full Text
View/download PDF

4. Hidradenitis suppurativa is associated with non-alcoholic fatty liver disease:A cross-sectional study

Author

González-Villanueva, Iris, DE GRACIA, Cristina, Planells, Mariana, Poveda, Inés, Álvarez, Pedro, Schneller-Pavelescu, Luca, Betlloch, Isabel, Jemec, Gregor B., Ramos, José M., Pascual, José C., González-Villanueva, Iris, DE GRACIA, Cristina, Planells, Mariana, Poveda, Inés, Álvarez, Pedro, Schneller-Pavelescu, Luca, Betlloch, Isabel, Jemec, Gregor B., Ramos, José M., and Pascual, José C.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is currently the most common cause of end-stage liver disease. The aim of this controlled cross-sectional study was to as-sess the association between NAFLD and hidradenitis suppurativa. NAFLD was assessed using hepatic ultra-sound. A total of 125 patients with hidradenitis suppu-rativa and 120 patients without hidradenitis suppu-rativa were recruited, matched for age, sex and body mass index (< 25 or ≥ 25 kg/m2), a risk factor related to NAFLD. Both groups presented similar proportions of overweight or obesity (89.6% vs 90%). Patients with hidradenitis suppurativa presented significantly higher prevalence of NAFLD compared with those with non-hidradenitis suppurativa (57.6% vs 31.7%, p < 0.001). Multivariable analysis confirmed independent association between hidradenitis suppurativa and NAFLD (odds ratio 2.79, 95% confidence interval 1.48–5.25; p = 0.001) besides age, body mass index, hypertension and hypertransaminasaemia. Hidrade-nitis suppurativa is significantly associated with the development of NALFD regardless of the presence of classic metabolic risk factors.

Published
2020

7. Hidradenitis Suppurativa is Associated with Non-alcoholic Fatty Liver Disease: A Cross-sectional Study.

Author

GONZÁLEZ-VILLANUEVA, Iris, DE GRACIA, Cristina, PLANELLS, Mariana, POVEDA, Inés, ÁLVAREZ, Pedro, SCHNELLERPAVELESCU, Luca, BETLLOCH, Isabel, JEMEC, Gregor B., RAMOS, José M., and PASCUAL, José C.

Subjects
*HIDRADENITIS suppurativa, *FATTY liver, *BODY mass index, *CROSS-sectional method
Abstract

Non-alcoholic fatty liver disease (NAFLD) is currently the most common cause of end-stage liver disease. The aim of this controlled cross-sectional study was to assess the association between NAFLD and hidradenitis suppurativa. NAFLD was assessed using hepatic ultrasound. A total of 125 patients with hidradenitis suppurativa and 120 patients without hidradenitis suppurativa were recruited, matched for age, sex and body mass index (< 25 or = 25 kg/m²), a risk factor related to NAFLD. Both groups presented similar proportions of overweight or obesity (89.6% vs 90%). Patients with hidradenitis suppurativa presented significantly higher prevalence of NAFLD compared with those with non-hidradenitis suppurativa (57.6% vs 31.7%, p < 0.001). Multivariable analysis confirmed independent association between hidradenitis suppurativa and NAFLD (odds ratio 2.79, 95% confidence interval 1.48-5.25; p = 0.001) besides age, body mass index, hypertension and hypertransaminasaemia. Hidradenitis suppurativa is significantly associated with the development of NALFD regardless of the presence of classic metabolic risk factors. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results